ジヒドロフィナステリド
ジヒドロフィナステリド 物理性質(zhì)
- 融點(diǎn) :
- 273-275 °C
- 沸點(diǎn) :
- 569.4±49.0 °C(Predicted)
- 比重(密度) :
- 1.051±0.06 g/cm3(Predicted)
- 貯蔵溫度 :
- −20°C
- 溶解性:
- クロロホルム（微量）、メタノール
- 酸解離定數(shù)(Pka):
- 15.94±0.70(Predicted)
- 外見 :
- 粉
- 色:
- 黃色
- 旋光度（Optical Rotation）:
- 55.5°(C=0.01g/ml MEOH)
- InChIKey:
- ZOIUUCNFVDJSJK-WSBQPABSSA-N
- SMILES:
- N1[C@@]2([H])[C@@](C)([C@@]3([H])CC[C@@]4(C)[C@]([H])([C@]3([H])CC2)CC[C@@H]4C(NC(C)(C)C)=O)CCC1=O
ジヒドロフィナステリド 価格
もっと(10)
| メーカー |
製品番號(hào) |
製品説明 |
CAS番號(hào) |
包裝 |
価格 |
更新時(shí)間 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCD448975 |
Dihydro Finasteride |
98319-24-5 |
500mg |
￥152400 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCD448975 |
Dihydro Finasteride |
98319-24-5 |
1g |
￥239500 |
2023-06-01 |
購入 |
|
Sigma-Aldrich Japan
|
O2757 |
≥90%, powder
3-Oxo-4-aza-5α-androstane-17β-(N-t-butylcarboxamide) ≥90%, powder |
98319-24-5 |
5mg |
￥28100 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCD448975 |
Dihydro Finasteride |
98319-24-5 |
25mg |
￥76500 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TRCD448975 |
Dihydro Finasteride |
98319-24-5 |
50mg |
￥93600 |
2024-03-01 |
購入 |
ジヒドロフィナステリド 化學(xué)特性,用途語,生産方法
化學(xué)的特性
White Solid
使用
The reduced product of Finasteride (F342000): a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitor
y process.
ジヒドロフィナステリド 上流と下流の製品情報(bào)
原材料
準(zhǔn)備製品
ジヒドロフィナステリド 生産企業(yè)
Global( 280)Suppliers
ジヒドロフィナステリド スペクトルデータ(1HNMR)
98319-24-5(ジヒドロフィナステリド)キーワード:
- 98319-24-5
- 3-OXO-4-AZA-5A-ANDROSTANE-17-BETA-(N-TERT-BUTYLCARBOXAMIDE)
- 3-OXO-4-AZA-5-ALPHA-ANDROSTANE-17-BETA-N-T-BUTYLCARBOXAMIDE
- N-(1,1-Dimethyl)-3-oxo-4-aza-5a-androstane-17b-carboxamide
- 3-OXO-4-AZA-5A-ANDROSTANE-17B-(N-T-*BUTY LCARBOXAMID
- (2R,3R,4BS,6AS,7S,9AS,9BS)-4A,6A-DIMETHYL-2-OXO-HEXADECAHYDRO-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE
- 3-Oxo-4-Aza-5A-Androstane-17B-(N-T-Butyl)Carboxamide
- N-(U-Dimethylcthyl)-3-Oxo-4-Aza-5-alpha-Androstane-17-beta-Carboxamide,Finasteride
- N-(U-Dimethylethyl)-3-Oxo-4" Aza-5o'-Androstane-17J6-Carboxamide
- N-(U- Dimethylcthyl)- 3-Oxo-4” Aza-5O’-Androstane -176-Carboxamide, Finasteride,
- N-TERT-BUTYL-3-OXO-4-AZA-5A-ANDROST-17BETA-CARBOXAMIDE
- N-TERT-BUTYL-3-OXO-4-AZA-5-ANDROST-17SS-CARBOXAMIDE
- 3-OXO-4-AZA-5ALPHA-ANDROSTANE-17-BETA-(N-TERT-BUTYLCARBOXAMIDE)
- 3-Oxo-4-aza-5-alpha-androstane-17-beta-N-t-
- 3-OXO-4-AZA-5-ALPHA-ANDROSTANE-17-BELTA-N-T-BUTYLCARBOXAMIDE
- DIHYDROPROSCAR
- 4-Aza-N-(1,1-dimethylethyl)-3-oxo-5ALPHA-androstane-17B-carboxamide
- 3-Oxo-4-aza-5α-androstane-17β-(N-t-butylcarboxamide)
- 3-Oxo-4-aza-5A-androstane-17beta-(N-T-butylcarboxamide)
- N-TERT-BUTYL-3-OXO-4-AZA-5ALPHA-ANDROST-17BETA-CARBOXAMIDE
- F9 / FINASTERIDE INTERMEDIATE
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-DiMethylethyl)hexadecahydro-4a,6a-diMethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxaMide
- (5α,17β)-N-(1,1-DiMethylethyl)-3-oxo-4-azaandrostane-17-carboxaMide
- [4aR-(4aα,4bβ,6aα,7α,9aβ,9bα,11aβ)]-N-(1,1-DiMethylethyl)hexadecahydro-4a,6a-diMethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxaMide
- 1,2-Dihydrofinasteride
- 3-Oxo-4-aza-5α-androstan-17β-carboxylic acid N-(tert-butyl)aMide
- N-(tert-Butyl)-3-oxo-4-aza-5α-androstane-17β-carboxaMide
- 17-beta-(n-butylcarbaMoyl)-4-aza-5-alpha-androstan-3-one
- (5,ALPHA, 17BETA)-N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZA-5-ANDROSTANE-17-CARBOXAMIDE
- 17β-(t-Butylcarbamoyl)-4-aza-5α-androstan-3-one (F9)
- 17 B-(T-BUTYLCARBAMOYL) -4-AZA-5 ANDROSTAN- 3-ONE
- ジヒドロフィナステリド
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-ブチル-4a,6a-ジメチル-2-オキソ-ヘキサデカヒドロ-1H-インデノ[5,4-f]キノリン-7-カルボキサミド
- N-(tert-ブチル)-3-オキソ-4-アザ-5α-アンドロスタン-17β-カルボアミド
- N-tert-ブチル-3-オキソ-4-アザ-5α-アンドロスタン-17β-カルボアミド